angelicin has been researched along with Pneumonia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, N; Deng, YH; Feng, HH; Gao, HY; Li, RS; Liu, F; Soromou, LW; Sun, GQ | 1 |
1 other study(ies) available for angelicin and Pneumonia
Article | Year |
---|---|
Angelicin regulates LPS-induced inflammation via inhibiting MAPK/NF-κB pathways.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Cell Line; Cell Survival; Disease Models, Animal; Furocoumarins; Interleukin-6; Lipopolysaccharides; Macrophages; Male; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; NF-kappa B; Pneumonia; Tumor Necrosis Factor-alpha | 2013 |